Related Experiment Video
Updated: Nov 18, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
Javier Donate-Correa1,2, Carla M Ferri1,3, Fátima Sánchez-Quintana1,3
1Unidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Insights
Diabetic kidney disease (DKD) involves inflammation. Understanding these inflammatory pathways is key to developing new treatments for this diabetes complication.
Area of Science:
- Nephrology
- Immunology
- Endocrinology
Background:
- Diabetic kidney disease (DKD) is a major cause of end-stage renal disease and cardiovascular complications in diabetes mellitus.
- Current DKD management focuses on controlling hyperglycemia and hypertension.
- Inflammation is increasingly recognized as a central pathogenic process in DKD, though its precise mechanisms are not fully understood.
Purpose of the Study:
- To review the inflammation-related pathogenic mechanisms underlying DKD.
- To explore the therapeutic potential of novel anti-inflammatory strategies for DKD.
Main Methods:
- Literature review of studies on DKD pathogenesis and inflammation.
- Analysis of current and emerging anti-inflammatory therapeutic approaches.
Main Results:
- Inflammation plays a critical role in the development and progression of DKD.
- Specific inflammatory pathways contribute to kidney damage in diabetic patients.
- Emerging anti-inflammatory therapies show promise for DKD treatment.
Conclusions:
- Targeting inflammation represents a promising therapeutic avenue for managing DKD.
- Further research into DKD inflammatory mechanisms is crucial for clinical advancement.
- Anti-inflammatory strategies could offer new hope for patients with diabetic kidney disease.
Abstract:
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and a main contributing factor for cardiovascular morbidity and mortality in patients with diabetes mellitus. Strategies employed to delay the progression of this pathology focus on the control of traditional risk factors, such as hyperglycemia, and elevated blood pressure. Although the intimate mechanisms involved in the onset and progression of DKD remain incompletely understood, inflammation is currently recognized as one of the main underlying processes. Untangling the mechanisms involved in the appearing of a harmful inflammatory response in the diabetic patient is crucial for the development of new therapeutic strategies. In this review, we focus on the inflammation-related pathogenic mechanisms involved in DKD and in the therapeutic utility of new anti-inflammatory strategies.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

